General Information
Drug ID
DR00254
Drug Name
Sitagliptin
Synonyms
(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE; (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; Janumet; Januvia; Januvia (TN); Januvia (merck & Co.); MK-0431; Sitagliptan; Sitagliptin (Prop.INN); Sitagliptin phosphate; Xelevia
Drug Type
Small molecular drug
Indication Type 2 diabetes [ICD11: 5A11] Approved [1]
Therapeutic Class
Hypoglycemic Agents
Structure
3D MOL 2D MOL
Formula
C16H15F6N5O
Canonical SMILES
C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N
InChI
InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1
InChIKey
MFFMDFFZMYYVKS-SECBINFHSA-N
CAS Number
CAS 486460-32-6
Pharmaceutical Properties Molecular Weight 407.31 Topological Polar Surface Area 77
Heavy Atom Count 28 Rotatable Bond Count 4
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 10
XLogP
0.7
PubChem CID
4369359
PubChem SID
103502876 , 112947540 , 117695427 , 126669712 , 126731480 , 134337929 , 135206675 , 136339733 , 137005783 , 143037551 , 143497677 , 14904024 , 152028143 , 152164204 , 152164205 , 152238548 , 152344340 , 160646743 , 160964592 , 162201432 , 16466401 , 164784279 , 164824529 , 164846813 , 165235282 , 165245552 , 165702336 , 170499559 , 174006349 , 174529510 , 175268642 , 178102906 , 179231014 , 186005103 , 35668584 , 46393524 , 46505822 , 46511716 , 46513917 , 46530623 , 48034814 , 50070925 , 56365842 , 78231257 , 7885474 , 85789641 , 92307950 , 96025201 , 9656038 , 99443685
ChEBI ID
ChEBI:40237
TTD Drug ID
D0U2JP
DT(s) Transporting This Drug OAT3 Transporter Info Organic anion transporter 3 Substrate [2]
OCT-1 Transporter Info Organic cation transporter 1 Substrate [3]
P-GP Transporter Info P-glycoprotein 1 Substrate [4]
Drug-Transporter Activity Data
Drug-Transporter Activity Data OAT3 Transporter Info Km = 162 microM Chinese hamster ovary (CHO) cells-OAT3 [2]
References
1 Sitagliptin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein. J Pharmacol Exp Ther. 2007 May;321(2):673-83.
3 265 effect of dietary cholesterol on gallbladder bile lithogenicity and gene expression in the enterohepatic axis of non-obese gallstone and control women. Journal of Hepatology, 2009, 50(09):S105-S106.
4 Tarascon Pocket Pharmacopoeia 2018 Classic Shirt-Pocket Edition.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.